{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:15:40Z","timestamp":1790648140874,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s40265-015-0521-8","type":"journal-article","created":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T05:00:02Z","timestamp":1448946002000},"page":"111-121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Sumatriptan\/Naproxen Sodium: A Review in Migraine"],"prefix":"10.1007","volume":"76","author":[{"given":"Yahiya Y.","family":"Syed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,1]]},"reference":[{"key":"521_CR1","doi-asserted-by":"crossref","unstructured":"The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629\u2013808.","DOI":"10.1177\/0333102413485658"},{"key":"521_CR2","unstructured":"American Headache Society. Epidemiology and impact of headache and migraine. http:\/\/www.americanheadachesociety.org . Accessed 11 Nov 2015."},{"issue":"Suppl 1","key":"521_CR3","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.4103\/0972-2327.99993","volume":"15","author":"PJ Goadsby","year":"2012","unstructured":"Goadsby PJ. Pathophysiology of migraine. Ann Indian Acad Neurol. 2012;15(Suppl 1):S15\u201322.","journal-title":"Ann Indian Acad Neurol."},{"issue":"2","key":"521_CR4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/157488907780832733","volume":"2","author":"AV Krymchantowski","year":"2007","unstructured":"Krymchantowski AV, Jevoux Cda C. The experience of combining agents, specially triptans and non steroidal anti-inflammatory drugs, for the acute treatment of migraine\u2014a review. Recent Pat CNS Drug Discov. 2007;2(2):141\u20134.","journal-title":"Recent Pat CNS Drug Discov."},{"issue":"4","key":"521_CR5","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1526-4610.2011.02058.x","volume":"52","author":"A Blumenfeld","year":"2012","unstructured":"Blumenfeld A, Gennings C, Cady R. Pharmacological synergy: the next frontier on therapeutic advancement for migraine. Headache. 2012;52(4):636\u201347.","journal-title":"Headache."},{"issue":"1","key":"521_CR6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/head.12499","volume":"55","author":"MJ Marmura","year":"2015","unstructured":"Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies. Headache. 2015;55(1):3\u201320.","journal-title":"Headache."},{"issue":"6","key":"521_CR7","doi-asserted-by":"crossref","first-page":"e1411","DOI":"10.1542\/peds.2011-2455","volume":"129","author":"FJ Derosier","year":"2012","unstructured":"Derosier FJ, Lewis D, Hershey AD, et al. Randomized trial of sumatriptan and naproxen sodium combination in adolescent migraine. Pediatrics. 2012;129(6):e1411\u201320.","journal-title":"Pediatrics"},{"issue":"9","key":"521_CR8","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/j.1526-4610.2011.01965.x","volume":"51","author":"SA McDonald","year":"2011","unstructured":"McDonald SA, Hershey AD, Pearlman E, et al. Long-term evaluation of sumatriptan and naproxen sodium for the acute treatment of migraine in adolescents. Headache. 2011;51(9):1374\u201387.","journal-title":"Headache."},{"issue":"4","key":"521_CR9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/head.12555","volume":"55","author":"P Winner","year":"2015","unstructured":"Winner P, Linder S, Hershey AD. Consistency of response to sumatriptan\/naproxen sodium in a randomized placebo-controlled, cross-over study for the acute treatment of migraine in adolescence. Headache. 2015;55(4):519\u201328.","journal-title":"Headache."},{"issue":"12","key":"521_CR10","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1212\/01.WNL.0000147332.41993.90","volume":"63","author":"D Lewis","year":"2004","unstructured":"Lewis D, Ashwal S, Hershey A, et al. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004;63(12):2215\u201324.","journal-title":"Neurology."},{"issue":"3","key":"521_CR11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1526-4610.2005.05050.x","volume":"45","author":"DW Lewis","year":"2005","unstructured":"Lewis DW, Winner P, Wasiewski W. The placebo responder rate in children and adolescents. Headache. 2005;45(3):232\u20139.","journal-title":"Headache."},{"key":"521_CR12","doi-asserted-by":"crossref","unstructured":"Winner P. Pediatric and adolescent migraine. http:\/\/www.americanheadachesociety.org . Accessed 11 Nov 2015.","DOI":"10.1016\/j.spen.2015.09.001"},{"key":"521_CR13","unstructured":"Pernix Therapeutics. Treximet\u00ae (sumatriptan\/naproxen sodium): US Prescribing Information. 2015. http:\/\/www.treximet.com . Accessed 25 Jun 2015."},{"key":"521_CR14","unstructured":"Pernix Therapeutics. What is RT Technology\u2122? 2015. http:\/\/www.treximet.com . Accessed 28 Oct 2015."},{"issue":"12","key":"521_CR15","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s40265-013-0099-y","volume":"73","author":"LP Yang","year":"2013","unstructured":"Yang LP. Sumatriptan\/naproxen sodium: a review of its use in adult patients with migraine. Drugs. 2013;73(12):1339\u201355.","journal-title":"Drugs."},{"issue":"1","key":"521_CR16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/head.12211","volume":"54","author":"R Cady","year":"2014","unstructured":"Cady R, O\u2019Carroll P, Dexter K, et al. SumaRT\/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study. Headache. 2014;54(1):67\u201379.","journal-title":"Headache."},{"issue":"5","key":"521_CR17","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/1756285613499788","volume":"6","author":"S Landy","year":"2013","unstructured":"Landy S, Hoagland R, Hoagland D, et al. Sumatriptan\/naproxen sodium combination versus its components administered concomitantly for the acute treatment of migraine: a pragmatic, crossover, open-label outcomes study. Ther Adv Neurol Disord. 2013;6(5):279\u201386.","journal-title":"Ther Adv Neurol Disord."},{"issue":"6","key":"521_CR18","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2165\/00003495-200060060-00003","volume":"60","author":"P Tfelt-Hansen","year":"2000","unstructured":"Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs. 2000;60(6):1259\u201387.","journal-title":"Drugs."},{"issue":"45","key":"521_CR19","doi-asserted-by":"crossref","first-page":"34950","DOI":"10.1074\/jbc.M110.162982","volume":"285","author":"KC Duggan","year":"2010","unstructured":"Duggan KC, Walters MJ, Musee J, et al. Molecular basis for cyclooxygenase inhibition by the non-steroidal anti-inflammatory drug naproxen. J Biol Chem. 2010;285(45):34950\u20139.","journal-title":"J Biol Chem"},{"issue":"14","key":"521_CR20","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1212\/WNL.0000000000001443","volume":"84","author":"NC Chai","year":"2015","unstructured":"Chai NC, Gelaye B, Tietjen GE, et al. Ictal adipokines are associated with pain severity and treatment response in episodic migraine. Neurology. 2015;84(14):1409\u201318.","journal-title":"Neurology."},{"issue":"1","key":"521_CR21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1526-4610.2011.02048.x","volume":"52","author":"CV Vause","year":"2012","unstructured":"Vause CV, Durham PL. Identification of cytokines and signaling proteins differentially regulated by sumatriptan\/naproxen. Headache. 2012;52(1):80\u20139.","journal-title":"Headache."},{"issue":"4","key":"521_CR22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/head.12052","volume":"53","author":"KR Edwards","year":"2013","unstructured":"Edwards KR, Rosenthal BL, Farmer KU, et al. Evaluation of sumatriptan-naproxen in the treatment of acute migraine: a placebo-controlled, double-blind, cross-over study assessing cognitive function. Headache. 2013;53(4):656\u201364.","journal-title":"Headache."},{"issue":"12","key":"521_CR23","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1751-7176.2011.00554.x","volume":"13","author":"WB White","year":"2011","unstructured":"White WB, Derosier FJ, Thompson AH, et al. Evaluation of the migraine treatment sumatriptan\/naproxen sodium on blood pressure following long-term administration. J Clin Hypertens (Greenwich). 2011;13(12):910\u20136.","journal-title":"J Clin Hypertens (Greenwich)."},{"issue":"3","key":"521_CR24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1526-4610.2009.01606.x","volume":"50","author":"LJ Haberer","year":"2010","unstructured":"Haberer LJ, Walls CM, Lener SE, et al. Distinct pharmacokinetic profile and safety of a fixed-dose tablet of sumatriptan and naproxen sodium for the acute treatment of migraine. Headache. 2010;50(3):357\u201373.","journal-title":"Headache."},{"issue":"3","key":"521_CR25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/2160763X12447302","volume":"1","author":"A Berges","year":"2012","unstructured":"Berges A, Robertson J, Upward J, et al. Pharmacokinetics, safety, and tolerability following the administration of a single dose of a combination tablet containing sumatriptan and naproxen sodium in adolescent patients with migraine and in healthy adult volunteers. Clin Pharmacol Drug Dev. 2012;1(3):85\u201392.","journal-title":"Clin Pharmacol Drug Dev."},{"issue":"4","key":"521_CR26","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/0333102413508242","volume":"34","author":"S Silberstein","year":"2014","unstructured":"Silberstein S, McDonald SA, Goldstein J, et al. Sumatriptan\/naproxen sodium for the acute treatment of probable migraine without aura: a randomized study. Cephalalgia. 2014;34(4):268\u201379.","journal-title":"Cephalalgia"},{"issue":"7","key":"521_CR27","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1526-4610.2009.01458.x","volume":"49","author":"NT Mathew","year":"2009","unstructured":"Mathew NT, Landy S, Stark S, et al. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life. Headache. 2009;49(7):971\u201382.","journal-title":"Headache."},{"issue":"13","key":"521_CR28","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/jama.297.13.1443","volume":"297","author":"JL Brandes","year":"2007","unstructured":"Brandes JL, Kudrow D, Stark SR, et al. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA. 2007;297(13):1443\u201354.","journal-title":"JAMA"},{"issue":"8","key":"521_CR29","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1468-2982.2008.01806.x","volume":"29","author":"RB Lipton","year":"2009","unstructured":"Lipton RB, Dodick DW, Adelman JU, et al. Consistency of response to sumatriptan\/naproxen sodium in a placebo-controlled, crossover study. Cephalalgia. 2009;29(8):826\u201336.","journal-title":"Cephalalgia"},{"issue":"2","key":"521_CR30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1212\/01.wnl.0000316800.22949.20","volume":"71","author":"SD Silberstein","year":"2008","unstructured":"Silberstein SD, Mannix LK, Goldstein J, et al. Multimechanistic (sumatriptan-naproxen) early intervention for the acute treatment of migraine. Neurology. 2008;71(2):114\u201321.","journal-title":"Neurology."},{"issue":"1","key":"521_CR31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/AOG.0b013e3181a98e4d","volume":"114","author":"LK Mannix","year":"2009","unstructured":"Mannix LK, Martin VT, Cady RK, et al. Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials. Obstet Gynecol. 2009;114(1):106\u201313.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"521_CR32","first-page":"53","volume":"9","author":"S Landy","year":"2007","unstructured":"Landy S, DeRossett SE, Rapoport A, et al. Two double-blind, multicenter, randomized, placebo-controlled, single-dose studies of sumatriptan\/naproxen sodium in the acute treatment of migraine: function, productivity, and satisfaction outcomes. MedGenMed. 2007;9(2):53.","journal-title":"MedGenMed."},{"issue":"6","key":"521_CR33","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.55.6.754","volume":"55","author":"SD Silberstein","year":"2000","unstructured":"Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55(6):754\u201362.","journal-title":"Neurology."},{"issue":"3","key":"521_CR34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40272-013-0019-3","volume":"15","author":"C Wober-Bingol","year":"2013","unstructured":"Wober-Bingol C. Pharmacological treatment of acute migraine in adolescents and children. Paediatr Drugs. 2013;15(3):235\u201346.","journal-title":"Paediatr Drugs"},{"issue":"6","key":"521_CR35","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/head.12550","volume":"55","author":"WJ Becker","year":"2015","unstructured":"Becker WJ. Acute migraine treatment in adults. Headache. 2015;55(6):778\u201393.","journal-title":"Headache."},{"issue":"20","key":"521_CR36","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1001\/jama.284.20.2599","volume":"284","author":"RB Lipton","year":"2000","unstructured":"Lipton RB, Stewart WF, Stone AM, et al. Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) Study: a randomized trial. JAMA. 2000;284(20):2599\u2013605.","journal-title":"JAMA"},{"issue":"1","key":"521_CR37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40258-014-0129-2","volume":"13","author":"CM Runken","year":"2015","unstructured":"Runken CM, Goodwin B, Shah M, et al. Migraine-related healthcare resource use and costs for subjects prescribed fixed-dose combination sumatriptan\/naproxen sodium vs. single-entity oral triptans in a managed care population in the USA. Appl Health Econ Health Policy. 2015;13(1):109\u201320.","journal-title":"Appl Health Econ Health Policy."}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-015-0521-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40265-015-0521-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-015-0521-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T23:24:24Z","timestamp":1567380264000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40265-015-0521-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["521"],"URL":"https:\/\/doi.org\/10.1007\/s40265-015-0521-8","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,1]]}}}